Moderna shows robust antibody levels six months into study

[left-of-center2012]

Moderna’s mRNA Covid-19 vaccine shows robust antibody levels at six months, according to a research letter published Tuesday in The New England Journal of Medicine.

Protection from the vaccine is expected to last longer than six months, but we’ll only know how long it works when there is more data from late-stage clinical trials. The company is continuing to study this.

Last week, a separate study showed that the Pfizer/BioNTech Covid-19 vaccine is 91.3% effective six months after the second dose, and 100% effective against severe disease. Moderna’s previous interim results showed it was 94.1% effective ...

https://www.cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-04-06-21/h_4097011d5334e7b5ee9c5e811c16dd98

[Shermann]

1. Have they figured out how to measure the T-cells yet?

Antibodies are only part of the equation.